CHRISTOPHER EARNHARDT: Open Payments
NPI 1699762948 · MINDEN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 46 payments from 13 companies in 2025. Trend: 2023 $900 · 2024 $956 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $265 |
| PFIZER INC. | 11 | $185 |
| Novo Nordisk Inc | 5 | $89 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| SANOFI PASTEUR INC. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
Products named: VRAYLAR, PREVNAR 20, NURTEC ODT, UBRELVY, Ozempic, LINZESS, QULIPTA, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
